亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南偉都化工有限公司  

醫藥原料藥和醫藥中間體

搜索
新聞中心
產品分類
  • 暫無分類
聯系方式
  • 聯系人:姚銳
  • 電話:0531-88873471
  • 郵件:wedochem@gmail.com
  • 傳真:0531-88873470
  • QQ:1783747865
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 鹽酸氯己定 3697-42-5
鹽酸氯己定 3697-42-5
單價 面議對比
詢價 暫無
發貨 山東濟南市付款后3天內
品牌 偉都化工
型號 3697-42-5
規格 99%
過期 長期有效
更新 2013-11-25 11:41
 
詳細信息
鹽酸氯己定 3697-42-5
 
英文名  Chlorhexidine hydrochloride
別名  Chlorhexidine dihydrochloride; Hexamethylenebis(5-(p-chlorophenyl)biguanide) dihydrochloride; Hibitane chlorhexidine dihydrochloride; 1,1'-Hexamethylenebis(5-(p-chlorophenyl))-biguanide dihydrochloride; AY 5312
產品名稱  鹽酸氯己定; 鹽酸洗必泰; 1,1'-己基雙[5-(對氯苯基)雙胍]鹽酸鹽
 
分子式  C22H30Cl2N10.2(HCl);C22H32Cl4N10
分子量  578.37
CAS 登錄號  3697-42-5
用  途 用作表面活性型殺菌劑,具有相當強的廣譜抑菌、殺菌作用,對革蘭氏陽性菌及革蘭氏陰性菌均有效
©2025 濟南偉都化工有限公司 版權所有   技術支持:化工網   訪問量:22778  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |